454 Life Sciences Corporation, a pioneering entity in the biotechnology sector, is headquartered in the United States. Founded in 2000, the company has made significant strides in the field of next-generation sequencing (NGS), revolutionising genomic research and diagnostics. With a focus on providing advanced sequencing solutions, 454 Life Sciences offers unique products that enable researchers to conduct high-throughput DNA sequencing with unparalleled accuracy and speed. Their innovative technologies have positioned them as a leader in the genomics industry, catering to a diverse clientele that includes academic institutions, pharmaceutical companies, and clinical laboratories. Notable achievements include the development of the 454 Sequencing System, which has set benchmarks for efficiency in genomic analysis. As a key player in the NGS market, 454 Life Sciences continues to drive advancements in personalised medicine and genomic research, solidifying its reputation as a trusted partner in the life sciences community.
We don't have data for 454 Life Sciences Corporation, but we can show you information about their parent organization instead.
View parent company